Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.

The goal of this clinical trial is to learn if a modification to metaxalone 640 mg can reduce low back and leg pain. The participants will be 18 to 80 years old, healthy with newly occurring back or leg pain. The main question aims to compare a group taking active treatment and a group taking a look-alike substance containing no active treatment. All participants will answer questions on Day 1, before treatment, and on 7-day after treatment, about: * Amount and quality of pain * Interference with physical activity * Interference with sleep

Participants needed: 50
Trial details
Phase: Phase 4Age: 18-80Biological sex: AllType: InterventionalSponsor: Primus PharmaceuticalsUpdated: May 12, 2026Locations: 24
Eligibility criteria

No clinically significant conditions impacting quality or quantity of pain [+3]

Current use of other skeletal relaxants [+2]

Status: Recruiting

Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis

This study is performed to consider the safety and healing ability of diosmin in patients with systemic sclerosis (scleroderma) and open sores on their fingers (digital ulcers). Two (2) out of three (3) participants will receive active product. The participants will have four (4) visits over eight (8) weeks. Physical exams and photos will be performed. A variety of questions will be asked describing level of pain and lifestyle changes.

Participants needed: 45
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Primus PharmaceuticalsUpdated: Dec 4, 2025Locations: 5
Eligibility criteria

Diagnosis of systemic sclerosis (scleroderma) [+2]

Infection or gangrene in ulcer [+5]